264 related articles for article (PubMed ID: 17718551)
1. Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase.
Torres RA; Korzekwa KR; McMasters DR; Fandozzi CM; Jones JP
J Med Chem; 2007 Sep; 50(19):4642-7. PubMed ID: 17718551
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase towards substituted benzaldehydes.
Panoutsopoulos GI; Beedham C
Acta Biochim Pol; 2004; 51(3):649-63. PubMed ID: 15448727
[TBL] [Abstract][Full Text] [Related]
3. Contribution of aldehyde oxidase, xanthine oxidase, and aldehyde dehydrogenase on the oxidation of aromatic aldehydes.
Panoutsopoulos GI; Kouretas D; Beedham C
Chem Res Toxicol; 2004 Oct; 17(10):1368-76. PubMed ID: 15487898
[TBL] [Abstract][Full Text] [Related]
4. Molybdenum hydroxylase super family shows circadian activity fluctuation in mice liver: emphasis on aldehyde hydroxylase and xanthine oxidase.
Al-Abbasi FA; Al-Sieni AI
Pak J Pharm Sci; 2010 Oct; 23(4):359-62. PubMed ID: 20884446
[TBL] [Abstract][Full Text] [Related]
5. Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate.
Yamaguchi Y; Matsumura T; Ichida K; Okamoto K; Nishino T
J Biochem; 2007 Apr; 141(4):513-24. PubMed ID: 17301077
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of isovanillin by aldehyde oxidase, xanthine oxidase, aldehyde dehydrogenase and liver slices.
Panoutsopoulos GI; Beedham C
Pharmacology; 2005 Mar; 73(4):199-208. PubMed ID: 15627845
[TBL] [Abstract][Full Text] [Related]
7. Increasing recognition of the importance of aldehyde oxidase in drug development and discovery.
Garattini E; Terao M
Drug Metab Rev; 2011 Aug; 43(3):374-86. PubMed ID: 21428696
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of flavonoids on molybdenum hydroxylases activity.
Rashidi MR; Nazemiyeh H
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):133-52. PubMed ID: 20095789
[TBL] [Abstract][Full Text] [Related]
9. [Advances in the study of aldehyde oxidases].
Mi JQ; Li Y
Yao Xue Xue Bao; 2014 May; 49(5):582-9. PubMed ID: 25151725
[TBL] [Abstract][Full Text] [Related]
10. The oxidation of azaheterocycles with mammalian liver aldehyde oxidase.
Stubley C; Stell JG; Mathieson DW
Xenobiotica; 1979 Aug; 9(8):475-84. PubMed ID: 516790
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic oxidation of phthalazine with guinea pig liver aldehyde oxidase and liver slices: inhibition by isovanillin.
Panoutsopoulos GI; Beedham C
Acta Biochim Pol; 2004; 51(4):943-51. PubMed ID: 15625566
[TBL] [Abstract][Full Text] [Related]
12. Effects of Phenothiazines on Aldehyde Oxidase Activity Towards Aldehydes and N-Heterocycles: an In Vitro and In Silico Study.
Deris-Abdolahpour F; Abdolalipouran-Sadegh L; Dastmalchi S; Hamzeh-Mivehroud M; Zarei O; Dehgan G; Rashidi MR
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):275-286. PubMed ID: 30382490
[TBL] [Abstract][Full Text] [Related]
13. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
Zientek M; Jiang Y; Youdim K; Obach RS
Drug Metab Dispos; 2010 Aug; 38(8):1322-7. PubMed ID: 20444863
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of human liver aldehyde oxidase by raloxifene.
Obach RS
Drug Metab Dispos; 2004 Jan; 32(1):89-97. PubMed ID: 14709625
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase for methyl- and nitrobenzaldehydes.
Veskoukis AS; Kouretas D; Panoutsopoulos GI
Eur J Drug Metab Pharmacokinet; 2006; 31(1):11-6. PubMed ID: 16715777
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde oxidase: an enzyme of emerging importance in drug discovery.
Pryde DC; Dalvie D; Hu Q; Jones P; Obach RS; Tran TD
J Med Chem; 2010 Dec; 53(24):8441-60. PubMed ID: 20853847
[No Abstract] [Full Text] [Related]
17. Medicinal chemistry approaches to avoid aldehyde oxidase metabolism.
Pryde DC; Tran TD; Jones P; Duckworth J; Howard M; Gardner I; Hyland R; Webster R; Wenham T; Bagal S; Omoto K; Schneider RP; Lin J
Bioorg Med Chem Lett; 2012 Apr; 22(8):2856-60. PubMed ID: 22429467
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic oxidation of 2-phenylethylamine to phenylacetic acid and 2-phenylethanol with special reference to the metabolism of its intermediate phenylacetaldehyde.
Panoutsopoulos GI; Kouretas D; Gounaris EG; Beedham C
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):273-9. PubMed ID: 15569272
[TBL] [Abstract][Full Text] [Related]
19. A combined QM/MM study on the reductive half-reaction of xanthine oxidase: substrate orientation and mechanism.
Metz S; Thiel W
J Am Chem Soc; 2009 Oct; 131(41):14885-902. PubMed ID: 19788181
[TBL] [Abstract][Full Text] [Related]
20. Human liver aldehyde oxidase: inhibition by 239 drugs.
Obach RS; Huynh P; Allen MC; Beedham C
J Clin Pharmacol; 2004 Jan; 44(1):7-19. PubMed ID: 14681337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
